language:
Find link is a tool written by Edward Betts.searching for Ipilimumab 18 found (88 total)
alternate case: ipilimumab
Prostvac
(705 words)
[view diff]
exact match in snippet
view article
find links to article
Poole DJ, Parnes HL, Wright JJ, Dahut WL, Schlom J, Gulley JL (2012). "Ipilimumab and a poxviral vaccine targeting prostate-specific antigen in metastaticOligoclonal antibody (1,209 words) [view diff] exact match in snippet view article find links to article
currently approved is the cocktail of nivolumab (anti-PD1 antibody) and ipilimumab (anti-CTLA-4 antibody). It is used to treat melanomas, low-risk renalImmunologic checkpoint (385 words) [view diff] exact match in snippet view article find links to article
successful. In metastatic melanoma FDA approved an αCD152 monoclonal antibody Ipilimumab, that was found to prolong survival. In melanoma, nonsmall cell lung cancerTimeline of immunology (2,182 words) [view diff] exact match in snippet view article find links to article
asymptomatic stage IV prostate cancer. 2010 – First immune checkpoint inhibitor, ipilimumab (anti-CTLA-4), is approved by the FDA for treatment of stage IV melanomaAdenocarcinoma of the lung (4,877 words) [view diff] exact match in snippet view article find links to article
Howerver, the KEYNOTE-598 phase III trial has reported in 2021 that adding ipilimumab to pembrolizumab for NSCLC patients with PD-L1 tumor proportion scoreNon-small-cell lung cancer (5,239 words) [view diff] exact match in snippet view article find links to article
antibody. Nivolumab and Pembrolizumab are anti PD-1 monoclonal antibodies. Ipilimumab is a monoclonal antibody that targets Cytotoxic T-lymphocyte-associatedAcral lentiginous melanoma (1,258 words) [view diff] exact match in snippet view article find links to article
Therapies for metastatic melanoma include the biologic immunotherapy agents ipilimumab, pembrolizumab, and nivolumab; BRAF inhibitors, such as vemurafenib andMartin Glennie (193 words) [view diff] exact match in snippet view article find links to article
reported by The Daily Telegraph in August 2013. Glennie stressed that “Ipilimumab works by taking the brakes off part of the immune system called T cellsTumor-infiltrating lymphocytes (2,754 words) [view diff] exact match in snippet view article find links to article
Netherlands, researchers found that treatment with TILs was superior to ipilimumab in metastatic melanoma. Clinical trials using TILs to treat digestiveInterstitial nephritis (2,303 words) [view diff] exact match in snippet view article find links to article
Tyrosine kinase inhibitors (e.g. sunitinib), checkpoint inhibitors (e.g. ipilimumab, nivolumab, pembrolizumab, atezolizumab) Contrast agent Gadolininum basedLudwig Cancer Research (2,222 words) [view diff] exact match in snippet view article find links to article
PMID 18162241. Hodi, F. Stephen; et al. (19 August 2010). "Improved Survival with Ipilimumab in Patients with Metastatic Melanoma". The New England Journal of MedicineViralytics (2,428 words) [view diff] exact match in snippet view article find links to article
of care drug mitomycin C. MITCI (Melanoma Intra-Tumoural Cavatak and Ipilimumab). This Phase I study (ClinicalTrials.gov identifier NCT02307149), initiatedCatenin beta-1 (12,345 words) [view diff] exact match in snippet view article find links to article
undergoing clinical trials in combination with the FDA-approved dose of ipilimumab in patients who have advanced melanoma. The proteins BCL9 and BCL9L haveAndrogen receptor (9,362 words) [view diff] exact match in snippet view article find links to article
PMC 4201502. PMID 25184630. "Biomarker-Driven Therapy With Nivolumab and Ipilimumab in Treating Patients With Metastatic Hormone-Resistant Prostate CancerWolfram Samlowski (1,651 words) [view diff] exact match in snippet view article find links to article
Squib (Investigator initiated clinical trial): Evaluation of concurrent ipilimumab therapy and radiosurgery for oligometastatic but unresectable malignantBrady West (2,466 words) [view diff] exact match in snippet view article find links to article
involved in a study that underscored improved survival rates with the ipilimumab-radiotherapy combination in melanoma brain metastases, highlighting theMatthew Krummel (974 words) [view diff] exact match in snippet view article find links to article
bizjournals.com. "UC Berkeley Cancer Research Lab » The Story of Yervoy (Ipilimumab)". crl.berkeley.edu. Retrieved 26 June 2023. "Present at Creation of Nobel-WinningCrystal Mackall (2,782 words) [view diff] exact match in snippet view article find links to article
Howard; Mackall, Crystal L. (2016-03-15). "Phase I Clinical Trial of Ipilimumab in Pediatric Patients with Advanced Solid Tumors". Clinical Cancer Research